Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Terminated 1

Sponsor Class

OTHER_GOV 1

Study Type

Interventional 1

Sponsor

Cancer Type

Head & Neck 1

Conditions

Carcinoma, Non-Small-Cell Lung 4Pancreatic Neoplasms 3Squamous Cell Carcinoma of Head and Neck 2Uterine Cervical Neoplasms 1Rectal Neoplasms 1Neoplasms 1Muscle Invasive Bladder Cancer 1Laryngeal Neoplasms 1Laryngeal Diseases 1Inoperable œsophageal Cancer 1Head and Neck Neoplasms 1Esophageal Squamous Cell Carcinoma 1Esophageal Neoplasms 1Carcinoma, Squamous Cell 1Adenocarcinoma Of Esophagus 1

Interventions

Cetuximab 3N-benzhydryl-5-(2-(methylamino)propanamido)-3-(3-methylbutanoyl)-6-oxodecahydropyrrolo(1,2-a)(1,5)diazocine-8-carboxamide 2Cisplatin 2capmatinib 1Surveys and Questionnaires 1Radiotherapy, Intensity-Modulated 1Radiotherapy, Adjuvant 1Radiotherapy 1Proflavine 1Modafinil 1Minocycline 1Laryngectomy 1Interviews as Topic 1Emulsions 1Chemoradiotherapy 1Bupropion 1Bleomycin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Laryngeal Diseases × Chemoradiotherapy × Clear all
NCT00128817 2013-01-23

Concurrent Chemoradiation Versus Surgery With Adjuvant Therapy in Advanced Laryngopharyngeal Cancers

Tata Memorial Hospital

Phase 3 Terminated
900 enrolled
Head & Neck

Laryngeal Diseases, Laryngeal Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡